Fiona Taylor

Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials

Gianni D. Angelini, Fiona Taylor, Barnaby C Reeves et al. · The Lancet · 2002 · 570 citations

Medicine, Cardiology, Surgery +7

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

Kevin J. Harrington, Robert L. Ferris, George R. Blumenschein et al. · The Lancet Oncology · 2017 · 430 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial

David Cella, Viktor Grünwald, Paul Nathan et al. · The Lancet Oncology · 2016 · 218 citations

Medicine, Nephrology, Oncology +13

Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial

Martin Reck, Michael Schenker, Ki Hyeong Lee et al. · European Journal of Cancer · 2019 · 217 citations · Full text

Medicine, Oncology, Pharmacology +17

Depression — An independent predictor of early death in patients with advanced cancer

Mari Lloyd‐Williams, Chris Shiels, Fiona Taylor et al. · Journal of Affective Disorders · 2008 · 145 citations

Medicine, Oncology, Psychiatry +15